Press Releases 2016

Boston Scientific announces long-term data from the EVOLVE Trial of the SYNERGY™ Stent presented today at EuroPCR 2016 - May 19, 2016

Final, 5-year results from the EVOLVE Trial evaluating the Boston Scientific (NYSE: BSX) SYNERGY Stent support long-term safety and efficacy for the treatment of patients with de novo coronary artery disease...

Read more

Boston Scientific announces schedule of presentations at EuroPCR 2016 - May 13, 2016

Boston Scientific (NYSE: BSX) today announced its schedule of key data, including one late-breaking clinical trial, that will be featured at the  ...

Read more

Media Contacts

Rosie Ireland
Corporate Communications
+44 7585403359

Company Profile